Twist Bioscience (TWST) Share-based Compensation (2017 - 2026)

Twist Bioscience (TWST) has reported Share-based Compensation for 10 consecutive years, with $18.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Share-based Compensation fell 6.85% year-over-year to $18.9 million; the TTM figure through Mar 2026 stood at $43.7 million (up 484.74% YoY), while the FY2023 annual figure was $6.7 million, down 68.76% from the prior year.
• Share-based Compensation eased to $18.9 million in Q1 2026 per TWST's latest filing, from $24.8 million in the prior quarter.
• Across five years, Share-based Compensation topped out at $66.7 million in Q1 2022 and bottomed at -$48.4 million in Q3 2025.
• Historically, Share-based Compensation has averaged $5.5 million across 5 years, with a median of $11.0 million in 2023.
• On a YoY basis, Share-based Compensation climbed as much as 11065.85% in 2024 and fell as far as 1667.57% in 2024.
• Twist Bioscience's Share-based Compensation stood at -$2.3 million in 2022, then jumped by 573.98% to $11.0 million in 2023, then advanced by 8.81% to $12.0 million in 2024, then jumped by 106.6% to $24.8 million in 2025, then declined by 23.56% to $18.9 million in 2026.
• Business Quant data shows TWST's Share-based Compensation at $18.9 million in Q1 2026, $24.8 million in Q4 2025, and -$48.4 million in Q3 2025.